These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 41528)

  • 21. Evidence for the mode of antischistosomal action of hycanthone.
    Cioli D; Pica-Mattoccia L; Rosenberg S; Archer S
    Life Sci; 1985 Jul; 37(2):161-7. PubMed ID: 4010473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formation of promutagenic methylation damage in tissue-DNA of mice treated with antischistosomal agents.
    Badawi AF; Awney HA; Mostafa MH
    Cancer Lett; 1993 Dec; 75(3):167-73. PubMed ID: 8313351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A human strain of Schistosoma mansoni resistant to schistosomicides].
    Dias LC; Pedro RJ; Rigo E; Goto MM; Mafra GL
    Rev Saude Publica; 1978 Mar; 12(1):110. PubMed ID: 675134
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent advances in schistosome biochemistry.
    Coles GC
    Parasitology; 1984 Dec; 89 ( Pt 3)():603-37. PubMed ID: 6393006
    [No Abstract]   [Full Text] [Related]  

  • 25. Lack of correlation between schistosomicidal and anticholinergic properties of hycanthone and related drugs.
    Pica-Mattoccia L; Cioli D
    J Parasitol; 1986 Aug; 72(4):531-9. PubMed ID: 3783347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of agrimophol and its combination with niridazole on histochemical changes of Schistosoma japanicum and host liver].
    Yang YQ; Yang HZ; Le WJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Jun; 3 Suppl 1():56-9. PubMed ID: 6459880
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of oxamniquine on Schistosoma mansoni: some biological and biochemical observations.
    Goldberg M; Gold D; Flescher E; Lengy J
    Biochem Pharmacol; 1980 Mar; 29(5):838-40. PubMed ID: 20227968
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of schistosomiasis mansoni].
    de Carvalho SA
    Rev Paul Med; 1982; 99(2):26-8. PubMed ID: 7156674
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticholinergic properties of the antischistosomal drug hycanthone.
    Hillman GR; Senft AW
    Am J Trop Med Hyg; 1975 Sep; 24(5):827-34. PubMed ID: 1190369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
    Haese WH; Bueding E
    J Pharmacol Exp Ther; 1976 Jun; 197(3):703-13. PubMed ID: 180276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug resistance in schistosomiasis: a review.
    Bruce JI; Dias LC; Liang YS; Coles GC
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():143-50. PubMed ID: 3151088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
    Coelho PM; Lima e Silva FC; Nogueira-Machado JA
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Histological observations on the effects of artemether, fuvinazole and niridazole on Schistosoma japonicum schistosomulae in the mouse liver].
    Yang YQ; Yang HZ; Zhang CW
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):276-8. PubMed ID: 2954379
    [No Abstract]   [Full Text] [Related]  

  • 35. The schistosome enzyme that activates oxamniquine has the characteristics of a sulfotransferase.
    Pica-Mattoccia L; Carlini D; Guidi A; Cimica V; Vigorosi F; Cioli D
    Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():307-12. PubMed ID: 17308787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver monoamine oxidase (MAO) in liver homogenate of mice infected with Schistosoma mansoni and effect of certain therapeutic agents.
    Abdel Samad MM; Guirgis FK; Zeitoun R; El-Feki RF; Awadalla HN
    Tropenmed Parasitol; 1977 Dec; 28(4):554-9. PubMed ID: 203063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic activities and chemotherapy of Schistosoma mansoni.
    Magzoub M
    West Afr J Pharmacol Drug Res; 1976 Dec; 3(2):127-40. PubMed ID: 1029907
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-schistosomal drugs: observations on the mechanism of drug resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel.
    Brindley PJ; Sher A
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():157-61. PubMed ID: 3151089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical effects of niridazole on Schistosoma mansoni.
    Bueding E; Fisher J
    Mol Pharmacol; 1970 Sep; 6(5):532-9. PubMed ID: 5460003
    [No Abstract]   [Full Text] [Related]  

  • 40. Activity of oxamniquine at skin, pulmonary and sexual maturation phases, on a Schistosoma mansoni strain (R1) previously reported as resistant at the adult phase.
    Coelho PM; Ribeiro F; Mello RT; Lima e Silva FC; Nogueira-Machado JA
    Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():267-8. PubMed ID: 9921366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.